Cargando…
Endocannabinoids modulate human blood–brain barrier permeability in vitro
BACKGROUND AND PURPOSE: Endocannabinoids alter permeability at various epithelial barriers, and cannabinoid receptors and endocannabinoid levels are elevated by stroke, with potential neuroprotective effects. We therefore explored the role of endocannabinoids in modulating blood–brain barrier (BBB)...
Autores principales: | Hind, William H, Tufarelli, Cristina, Neophytou, Maria, Anderson, Susan I, England, Timothy J, O'Sullivan, Saoirse E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459020/ https://www.ncbi.nlm.nih.gov/pubmed/25651941 http://dx.doi.org/10.1111/bph.13106 |
Ejemplares similares
-
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries
por: Stanley, Christopher P., et al.
Publicado: (2016) -
The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation
por: Smith, Marie, et al.
Publicado: (2015) -
A Novel Transwell Blood Brain Barrier Model Using Primary Human Cells
por: Stone, Nicole L., et al.
Publicado: (2019) -
Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood–Brain Barrier Under Ischemic Conditions
por: Stone, Nicole L., et al.
Publicado: (2021) -
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB(1) activation
por: Stanley, Christopher P., et al.
Publicado: (2015)